Victory in HFpEF Again Evades ARNI Despite Hopeful Signals Victory in HFpEF Again Evades ARNI Despite Hopeful Signals

Close and yet so far: the ARNI sacubitril/valsartan, as it has done before, teased with post hoc signs of benefit in a preserved-EF heart failure, PARALLAX, without winning the primary endpoints.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news